Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Rodriguez

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
Trends in Immunology|October 29, 2002
Growth factor treatment of demyelinating disease: at last, a leap into the lightRichard M Ransohoff, Charles L Howe, Moses Rodriguez
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosisAllan J Bieber, Daren R Ure, Moses Rodriguez
Neurology|April 8, 2009
Invited article: human natural autoantibodies in the treatment of neurologic diseaseMoses Rodriguez, Arthur E Warrington, Larry R Pease
Neurobiology of Disease|November 23, 2006
Absence of perforin expression confers axonal protection despite demyelinationCharles L Howe, Jaimie D Adelson, Moses Rodriguez
Neurobiology of Disease|August 22, 2006
Disrupted spatial memory is a consequence of picornavirus infectionEric J Buenz, Moses Rodriguez, Charles L Howe
Journal of Neurology & Translational Neuroscience|November 11, 2014
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple SclerosisAleksandar Denic, Bharath Wootla, Laurie Zoecklein, et al.
Plos One|February 6, 2013
PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferationJens O Watzlawik, Arthur E Warrington, Moses Rodriguez
Journal of Neurology|September 1, 2006
MRI findings in benign multiple sclerosis are variableSean J Pittock, John H Noseworthy, Moses Rodriguez
Neurologic Clinics|November 22, 2017
Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal RepairHernan Nicolas Lemus, Arthur E Warrington, Moses Rodriguez
Journal of Neurovirology|October 29, 2002
ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelinationKristen M Drescher, Laurie J Zoecklein, Moses Rodriguez
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
Trends in Immunology|October 29, 2002
Growth factor treatment of demyelinating disease: at last, a leap into the lightRichard M Ransohoff, Charles L Howe, Moses Rodriguez
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosisAllan J Bieber, Daren R Ure, Moses Rodriguez
Neurology|April 8, 2009
Invited article: human natural autoantibodies in the treatment of neurologic diseaseMoses Rodriguez, Arthur E Warrington, Larry R Pease
Neurobiology of Disease|November 23, 2006
Absence of perforin expression confers axonal protection despite demyelinationCharles L Howe, Jaimie D Adelson, Moses Rodriguez
Neurobiology of Disease|August 22, 2006
Disrupted spatial memory is a consequence of picornavirus infectionEric J Buenz, Moses Rodriguez, Charles L Howe
Journal of Neurology & Translational Neuroscience|November 11, 2014
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple SclerosisAleksandar Denic, Bharath Wootla, Laurie Zoecklein, et al.
Plos One|February 6, 2013
PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferationJens O Watzlawik, Arthur E Warrington, Moses Rodriguez
Journal of Neurology|September 1, 2006
MRI findings in benign multiple sclerosis are variableSean J Pittock, John H Noseworthy, Moses Rodriguez
Neurologic Clinics|November 22, 2017
Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal RepairHernan Nicolas Lemus, Arthur E Warrington, Moses Rodriguez
Journal of Neurovirology|October 29, 2002
ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelinationKristen M Drescher, Laurie J Zoecklein, Moses Rodriguez
Pageof 26